(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.
Scholar Rock Holding's revenue in 2026 is $0.On average, 17 Wall Street analysts forecast SRRK's revenue for 2026 to be $2,766,155,185, with the lowest SRRK revenue forecast at $0, and the highest SRRK revenue forecast at $7,944,510,738. On average, 17 Wall Street analysts forecast SRRK's revenue for 2027 to be $17,987,246,341, with the lowest SRRK revenue forecast at $8,443,907,556, and the highest SRRK revenue forecast at $38,004,476,988.
In 2028, SRRK is forecast to generate $44,350,619,211 in revenue, with the lowest revenue forecast at $25,106,551,800 and the highest revenue forecast at $85,052,551,293.